Common questions about Rexulti (FAQ)
Q: Is it normal to feel more restless after starting Rexulti?
A: Official information lists Akathisia as a common side effect observed in clinical trials, which is described as a feeling of inner restlessness or the need to constantly move. This effect is a recognized part of the drug’s safety profile, particularly when treatment is started or when the dosage is adjusted. Concerns about persistent or bothersome effects are generally discussed with a healthcare professional.
Q: Can Rexulti interact with common over-the-counter pain relievers?
A: Regulatory information indicates that the dosage of Rexulti may need to be modified when taken with medicines that influence the CYP2D6 or CYP3A4 liver enzyme systems. While common over-the-counter pain relievers are not listed by name in the official prescribing information, regulatory sources generally emphasize that all co-administered medications should be discussed with a healthcare provider to assess potential enzyme interactions.
Q: What happens if you miss a dose of Rexulti?
A: According to the official administration protocol, if a dose is missed, it should be taken as soon as the user remembers. However, if it is almost time for the next scheduled daily dose, the missed dose should be skipped entirely, and the regular schedule should be continued. The official protocol states that two doses are not to be taken at the same time to make up for a missed dose.
Q: What kind of withdrawal symptoms are possible when stopping Rexulti?
A: Regulatory documents advise against the sudden cessation of this drug. A gradual dosage reduction is generally described in clinical practice to minimize the risk of acute adverse reactions upon stopping. Symptoms like nausea, vomiting, and non-motor effects have been noted with rapid discontinuation of similar medications.
Q: What is the difference between Rexulti and other antipsychotics?
A: Official labeling classifies Rexulti as an atypical antipsychotic that works as a Serotonin-Dopamine Activity Modulator (SDAM). This mechanism is distinguished by its unique profile of partial agonism at specific dopamine and serotonin receptors. This specific pattern of receptor engagement is recognized in the scientific literature for contributing to its specific clinical and safety profile.
Q: Why does the FDA document list a 'Black Box Warning' for Rexulti?
A: The Boxed Warning is the highest safety alert required by the FDA to call attention to serious safety risks. This is required for Rexulti due to two specific concerns: an increased risk of death in elderly patients with dementia-related psychosis, and an increased risk of suicidal thoughts and behaviors in children and young adults when used for depression.
Q: What are the general expectations about improvements when taking Rexulti for depression?
A: Clinical trials for the adjunctive treatment of Major Depressive Disorder (MDD) were typically designed as short-term, six-week studies. These studies observed patterns of change in depressive symptom severity. Observed populations showed effects measured on rating scales within the first few weeks, demonstrating that symptom improvements are generally measured within this short-term research period.
Q: What is the expected timeline for dose adjustments with Rexulti?
A: The official dosing protocol requires a titration period where the dosage is gradually increased under medical supervision. For conditions like schizophrenia in adults, the dose is increased after a few days, and for adjunctive MDD, the dose is typically adjusted at weekly intervals based on how the patient tolerates the medication and their response.
Q: How is Rexulti different from Abilify (aripiprazole)?
A: While both are categorized as atypical antipsychotics, official information describes Rexulti as having a lower level of intrinsic activity at the dopamine D2 receptor and higher potency at certain serotonin receptors compared to aripiprazole. This difference in receptor binding is a recognized aspect of its distinct pharmacological profile.
Q: How long does it usually take for Rexulti to start having an effect?
A: Clinical trials for the approved uses were typically conducted over a short-term duration, such as six weeks. During this research period, populations studied showed symptom changes over the first several weeks of treatment. This evidence suggests that effects are typically measured within the first few weeks in the research context.
Q: Does Rexulti affect sleep, like making you tired or causing insomnia?
A: Yes, official safety data lists effects on sleep and the central nervous system. Both somnolence (drowsiness or feeling tired) and insomnia (difficulty falling or staying asleep) are documented as adverse reactions observed during clinical trials.
Q: Are there any foods or drinks to avoid while taking Rexulti?
A: The medicine can be taken with or without food. However, official warnings advise that using alcohol during treatment can worsen certain nervous system side effects, such as dizziness and drowsiness. This combination is associated with the potential for impaired thinking and judgment.
Q: Is Rexulti safe to take with common medications for high blood pressure?
A: Regulatory documents warn that the medicine can cause orthostatic hypotension, which is a drop in blood pressure when changing position. Patients who have existing cardiovascular disease or who take other blood pressure-lowering agents are advised to be monitored, as the combination could increase this risk.
Q: Can Rexulti make you dizzy or affect your driving?
A: Yes, the official Medication Guide warns that the medicine may cause sleepiness, drowsiness, or dizziness. Due to the potential for impaired motor skills, official guidance suggests avoiding driving, operating machinery, or other dangerous activities until the individual knows how the medication impacts them.
Q: Is Rexulti a controlled substance?
A: No, according to the U.S. Drug Enforcement Administration (DEA), this medicine is not classified as a controlled substance. It is not listed as having a known potential for abuse or dependence based on official medical practice.
Q: Will I have to take Rexulti forever?
A: Official product information, particularly for its use as adjunctive therapy for Major Depressive Disorder, states that treatment requires periodic reassessment. This means official use requires that a healthcare professional periodically reassess the continued need for the medication and the appropriate dosage for long-term management.
Q: Does Rexulti affect sex drive or sexual function?
A: Official safety profiles list adverse reactions related to sexual function. Reported effects include decreased libido and, less commonly, other sexual dysfunction adverse events, which were noted during clinical trials.
Q: Are there special warnings about Rexulti for people with heart conditions?
A: Yes, official warnings advise caution in people with known cardiovascular or cerebrovascular disease, or conditions that predispose them to low blood pressure. This is due to the drug's potential to cause orthostatic hypotension and syncope (fainting).
Q: Is there a generic version of Rexulti available yet?
A: The active ingredient brexpiprazole has received FDA approval for generic use. However, the brand-name product still holds active patents and exclusivities for certain uses, which may legally prevent the generic from being marketed for all or some indications until those rights expire.
Q: Is Rexulti approved for treating bipolar disorder?
A: Official documents list the approved uses as adjunctive treatment for Major Depressive Disorder (MDD), Schizophrenia, and agitation associated with dementia due to Alzheimer’s disease. Bipolar disorder is not listed as an approved indication in the prescribing information.
Q: What should I do if a side effect of Rexulti is bothering me?
A: The official Medication Guide states that if side effects occur that are bothersome or do not go away, users are advised to contact their healthcare provider. Users are also advised not to stop taking the medicine or change the dosage without first talking to a healthcare professional.
Q: Can Rexulti interact with herbal supplements like St. John's Wort?
A: Yes, official labeling specifically lists St. John’s Wort as a strong enzyme inducer. This combination is documented as potentially requiring a dosage increase of Rexulti, as the supplement can decrease the drug's effectiveness by lowering its concentration in the body.
Q: Can I switch from another similar medication to Rexulti easily?
A: Official documentation requires that any change in medication be done only under the direct supervision and direction of a healthcare professional. They will determine the appropriate transition and dosage schedule.
Q: Is Rexulti safe for use while breastfeeding?
A: Official information indicates that it is not known if the medicine passes into breast milk or affects a nursing infant. The decision to use the medication while breastfeeding is described as requiring a careful consideration of the drug’s importance to the mother’s health against any potential risk to the child.
Q: Does taking Rexulti make you less able to handle heat?
A: Official documents warn that the drug may impair the body's ability to regulate its core temperature. Users are advised to take precautions to avoid overheating and dehydration, such as limiting strenuous exercise, exposure to extreme heat, and wearing excessive clothing.
